Literature DB >> 17578319

Protective effects and mechanism of total coptis alkaloids on a beta 25-35 induced learning and memory dysfunction in rats.

Zheng-qin Yang1, Su-fen Yang, Jun-qing Yang, Qi-xin Zhou, Shao-lin Li.   

Abstract

OBJECTIVE: To observe the effect of total coptis alkaloids (TCA) on beta -amyloid peptide (A beta 25-35) induced learning and memory dysfunction in rats, and to explore its mechanism.
METHODS: Forty male Wistar rats were randomly divided into four groups: the control group, the model group, the TCA low dose (60 mg/kg) group and the TCA high dose (120 mg/kg) group, 10 in each. A beta 25-35 (5microl, 2 microg/microl) was injected into bilateral hippocampi of each rat to induce learning and memory dysfunction. TCA were administered through intragavage for consecutive 15 days. Morris Water Maze test was used to assess the impairment of learning and memory; concentration of malondialdehyde (MDA) in cerebral cortex was determined by thiobarbituric acid reactive substance to indicate the level of lipid peroxidation in brain tissues; activity of manganese-superoxide dismutase (Mn-SOD) in cerebral cortex was determined by xanthine-oxidase to indicate the activity of the enzyme; and NF- kappa B protein expression in cerebral cortex was measured by SP immunohistochemistry.
RESULTS: (1) Morris Water Maze test showed that, during the 4 consecutive days of acquisition trials, the rats in the model group took longer latency and searching distance than those in the control group (P<0.01), which could be shortened by high dose TCA (P<0.05); during the spatial probe trial on the fifth day, the rats in the model group took shorter searching time and distance on the previous flat area than those in the control group (P<0.01), which could be prolonged after TCA treatment (for low dose group, P<0.05; for high dose group, P<0.01). (2) Analysis of cerebral cortical tissues showed that, compared with the control group, MDA level got significantly increased and Mn-SOD activity decreased in the model group (both P<0.01). After having been treated with TCA, the MDA level got significantly decreased (P<0.05 and P<0.01 respectively for low and high dose group), while relative increase of Mn-SOD activity only appeared in high dose group (P<0.05). (3) Immunohistochemistry analysis showed the protein expression of NF- kappa B got significantly increased after modeling, while high dose TCA can significantly inhibit it.
CONCLUSION: TCA could improve A beta 25-35 induced dysfunction of learning and memory in rats, and its protective mechanism is associated with its actions in decreasing MDA level, increasing Mn-SOD activity and inhibiting the expression of NF-kappa B in cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578319     DOI: 10.1007/s11655-007-0050-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  14 in total

1.  Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism.

Authors:  K T Akama; C Albanese; R G Pestell; L J Van Eldik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

2.  p38 kinase is activated in the Alzheimer's disease brain.

Authors:  K Hensley; R A Floyd; N Y Zheng; R Nael; K A Robinson; X Nguyen; Q N Pye; C A Stewart; J Geddes; W R Markesbery; E Patel; G V Johnson; G Bing
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

3.  Protective effects of bilobalide on amyloid beta-peptide 25-35-induced PC12 cell cytotoxicity.

Authors:  L J Zhou; W Song; X Z Zhu; Z L Chen; M L Yin; X F Cheng
Journal:  Acta Pharmacol Sin       Date:  2000-01       Impact factor: 6.150

4.  Huperzine A ameliorates the impaired memory of aged rat in the Morris water maze performance.

Authors:  J W Ye; Y Z Shang; Z M Wang; X C Tang
Journal:  Acta Pharmacol Sin       Date:  2000-01       Impact factor: 6.150

5.  Generation of Alzheimer amyloid beta peptide through nonspecific proteolysis.

Authors:  L O Tjernberg; J Näslund; J Thyberg; S E Gandy; L Terenius; C Nordstedt
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

6.  Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons.

Authors:  K Morimoto; K Yoshimi; T Tonohiro; N Yamada; T Oda; I Kaneko
Journal:  Neuroscience       Date:  1998-05       Impact factor: 3.590

7.  Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain.

Authors:  D Games; K M Khan; F G Soriano; P S Keim; D L Davis; K Bryant; I Lieberburg
Journal:  Neurobiol Aging       Date:  1992 Sep-Oct       Impact factor: 4.673

8.  The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain.

Authors:  M Emre; C Geula; B J Ransil; M M Mesulam
Journal:  Neurobiol Aging       Date:  1992 Sep-Oct       Impact factor: 4.673

9.  Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain.

Authors:  J A Clemens; D T Stephenson
Journal:  Neurobiol Aging       Date:  1992 Sep-Oct       Impact factor: 4.673

10.  In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.

Authors:  N W Kowall; A C McKee; B A Yankner; M F Beal
Journal:  Neurobiol Aging       Date:  1992 Sep-Oct       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.